Browsing: OrbusNeich Medical Group Holdings Limited

OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million

By Marie JonesMarch 8, 20250

– Proposes a Final Dividend of HK10 Cents per Share – Strengthens Foundation via Continuous Innovation, Global Sales Network, Enriched…

HealthCare

OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024

By Marie JonesAugust 16, 20240

– Robust R&D Pipeline Drives Continued Commercial Progress – Efficient Integration of Acquired Assets Supports Long-Term Growth Trajectory Results Highlights:…

HealthCare

OrbusNeich’s Joint Venture Kicks Off TricValve Clinical Trial in Mainland China

By Marie JonesApril 24, 20240

Enhances Patients’ Quality of Life with Minimally Invasive Transcatheter Therapy OrbusNeich Medical Group Holdings Limited (OrbusNeich or the HKG: 6929),…

BioTech

OrbusNeich Achieves Record-High Revenue and Net Profit of US$154 Million and US$45.1 Million Respectively, Recommends Final Dividend Payment of HK10 cents per Share

By Marie JonesMarch 7, 20240

Strategic M&A Initiatives Boost Product Portfolio and Market Penetration Reinforcing Business Pillars for Future Growth OrbusNeich Medical Group Holdings Limited…

BioTech

OrbusNeich Kicks Off Clinical Study of Scoreflex TRIO, Completing China’s First PCI Intervention Procedure with High-Pressure, Three-wire Scoring Balloon Dilatation Catheter

By Marie JonesMay 8, 20230

OrbusNeich Medical Group Holdings Limited (OrbusNeich or the Group; HKG: 6929), a major global medical device manufacturer specializing in interventional…